pretty exciting stuff.. easily distributed long shelf life pharmacy held wide use profile
plays into treatment in autoimmune conditions as a monotherapy..
check the list if you have not already....
https://www.aarda.org/diseaselist/
plenty of costly illnesses to society... as well as early cancer treatment without the need for chemo therapeutics.
if they can do it with imp321, they can do it with the whole product pipeline...
check out Freddy T's interview... https://www.immutep.com/investors-media/press-releases-72.html April 2021.
the biggest discovery for a soon to be widely used medication since paracetamol....https://en.wikipedia.org/wiki/Paracetamol
Ann: Immutep Reveals a New anti-LAG-3 Research Program, page-3
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |